the Ministry of Health in Ukraine, as part of our go-to-market strategy. We were also featured as one of the technologies to watch in 2022 by the Economist as well as 2023 Advanced Manufacturing Start-Up Technology Award Runner-Up. 

Our ultimate vision is to build an on-demand personalized tissue manufacturing platform that would be a one-stop shop for bioprinted tissues and organs; and, hence, to cut barriers to medical treatment for millions. 

A.D.A.M. is pioneering a service model, where the turnkey system will be installed and maintained by A.D.A.M. at the hospital for a monthly subscription fee. This specifically differentiates us from the current state of the market, significantly lowers the cost and paves the way for scaling of the platform to other markets by sector and geography. Currently there is no end-to-end solution for 3D printing in hospitals, and should the hospitals want such capability on-site they need to build it themselves. Setting up the Point-of-Care custom implant manufacturing process at the hospital is costly (>$1M), time-consuming (>2 yrs), and burdensome. The main issues of the existing approach arise due to its non-scalability - 3D companies are selling materials, printers and software separately. 

A.D.A.M.’s turnkey system that can be set up within 3 months, cut costs by >50%, increase profit/surgery, and generate additional revenues for hospital.